#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Topical Treatment of Psoriasis Part I: Psoriasis Vulgaris (Guidelines of the Czech Society of Dermatology and Venereology)


Authors: Benáková N. (hlavní Autor * *;  Koordinátor: Nina Benáková;  Expertní Skupina: Petr Arenberger;  Nina Benáková;  Hana Bučková;  Karel Ettler;  Dagmar Ditrichová;  Karel Pizinger;  Jiří Štork;  Yvetta Vantuchová;  Vladmír Vašků)
Authors‘ workplace: Dermatovenerologická klinika 1. LF UK a VFN Praha přednosta prof. MUDr. Jiří Štork, CSc ;  Dermatovenerologická ordinace, Medicínské centrum, Praha vedoucí lékař MUDr. Radek Klubal
Published in: Čes-slov Derm, 87, 2012, No. 1, p. 24-32
Category: Guidelines

Overview

Topical therapy is the mainstay in psoriasis treatment. In moderate to severe psoriasis it represents the main therapy, in severe psoriasis the adjunctive therapy. The recent American and German guidelines are dealing beside the systemic therapy and phototherapy also with topical therapy. Because of this and on the basis of prescription survey in the Czech Republic there is a need for becoming aware of the contemporary standard of topical psoriasis therapy. In this article the principles of topical therapy are presented for plaque psoriasis in out-patient settings, where the majority of patient are treated. These recommendations were completed by an experts´ group of Czech Dermatovenerological Society on the basis of world professional literature and with respect to local traditions and usage.

Key words:
plaque psoriasis – out-patient topical therapy – recommendations


Sources

1. ALBRECHT, L., BOURCIER, M., ASKENAZ, J., PAPP, K. for Canadian Psoriasis Guidelines Comittee Topical psoriasis therapy in the age of biologics. J. Cut. Med. Surg., 2011, 15, p. 309–321.

2. BENÁKOVÁ, N., ETTLER, K., ŠTORK, J., VAŠKŮ, V. Psoriáza nejen pro praxi. Triton: Praha, 2007, s. 173–193.

3. BENÁKOVÁ, N: Léčba psoriázy kštice. Referátový výběr, 2010, 52, 1, s. 31–36.

4. BEWLEY, A., PAGE, B. Maximizing adherence for optimal outcomes in psoriasis. JEADV, 2011, 25, suppl. 4, p. 9–14.

5. DEL ROSS, J., FRIEDLANDER, S. F. Corticosteroids: Options in the era of steroid-sparing therapy. JAAD, 2005, 53, S 50–58.

6. FELDMAN S. R., HORN, E. J., BALKRISHNAN, R. et al. Psoriasis: improving adherence to topical therapy. JAAD, 2008, 59, p. 1009–1016.

7. HORN, E. J., DOMM, S., KATZ, H. I., LEBWOHL, M., MROWIETZ, U., KRAGBALLE, K. Topical corticosteroids in psoriasis: strategies for improving safety. JEADV, 2010, 24, p. 119–124.

8. FOUÉRÉ, S., ADJADJ, L, PAWIN, H. (NICOLAS, J. F. Ed.). An update on patient perception, clinical evidence and on current prescription, instruction and application modalities for topical psoriasis treatments. JEADV, 2005,19, suppl. 3, p.1–6.

9. KERKHOF VAN DE, P. C. M., KRAGBALLE, K. Recommendation for the topical treatment of psoriasis. JEADV, 2005, 19, p. 495–499.

10. KERKHOF VAN de, P. C. M., PEUTER de, R., JANSEN, J. P. Mixed treatment comparison of a two-compound formulation product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris. Current Medical Research and Opinion, 2011, 27, p. 225–238.

11. KERKHOF VAN de, P. C. M., KRAGBALLE, K., SAEGERT, S., LEBWOHL, M. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the international psoriasis council. JEADV, 2011, 25, p. 1130–1139.

12. KOO, J. Y. M., NGUYEN, T. U., COLACO, S. M. Topical sequential therapy of psoriasis. In Koo, J. Y. M., Lebwohl, M., Lee, C. S. Mild-to-moderate psoriasis. Informa Healthcare: New York, London, 2009, p. 129–138.

13. KRAGBALLE, AUSTAD J., BARNES, L. et al. Efficacy results of 52-week, randomized, double-blind safety study of calcipotriol/betamethasone dipropionate two-compound product in the treatment of psoriasis vulgaris. Dermatology, 2006, 213, p. 319–326.

14. KUI, R., GYULAI, R., KEMÉNY, L. Hungarian evidence-based guidelines for the topical treatment of psoriasis vulgaris. (Bizonyítékokon alapuló irányelvek a psoriasis vulgaris kezeléséhez. Bőrgyógyászati). Útmutató, 2011, p. 93–109.

15. LEBWOHL, M. Combination, rotational and sequential therapy. In Weinstein, D. G., Gottlieb, A. B. Therapy of moderate-to-severe psoriasis. 2nd Ed., New York: Marcel Dekker, 2003, p. 179–195.

16. MENTHER, A. et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. JAAD, 2009, 60, p. 643–659.

17. MENTHER, A., KORMAN, N. J., CRAIG, A. E. et al. Guidelines for the management of psoriasis and psoriatic arthritis. Section 6. JAAD, 2011, 65, p. 137–174.

18. MROWIETZ, U., KRAGBALLE, K., REICH, K. et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch. Dermatol. Res., 2011, 303, p. 1–10.

19. MURPHY, G., REICH, K. In touch with psoriasis: topical treatments and current guidelines. JEADV, 2011, 25, suppl. 4, p. 1–8.

20. NAST, A., BOEHNCKE, W. H., MROWIETZ, U. et al. S-3 Leitlinie zur Therapie der Psoriasis vulgaris. Update 2011. JDDG, 2011, 9, suppl. 2, S1–104.

21. NORRIS, D. A. Mechanism of action of topical therapies and rationale for combination therapy. JAAD, 2005, 53, S17–25.

22. ORTONNE, J. P., CHIMENTI, S., LUGER T. et al. Scalp psoriasis: European consensus on grading and treatment algorithm. JEADV, 2009, 23, p.1435–1444.

23. SKLENÁŘ, Z. Magistraliter receptura v dermatologii. Galén: Praha, 2009, 441 s.

24. ŠTORK, J., ARENBERGER, P., PIZINGER, K. Dermatovenerologie. Galén: Praha, 2008, s. 185–191.

25. WOZEL, G., KLEIN, C. E., MROWIETZ, U. et al. S-1 Leitlinie zur Therapie der Psoriasis im behaarten Kopfes. JDDG, 2011, 9, p. 70–74.

Labels
Dermatology & STDs Paediatric dermatology & STDs
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#